Evidence map›Paper›PMID 36961026›Full record

ArticlePharmacy (Basel, Switzerland)2023

Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic.

Ellen Schellhase, Madeline Stanko, Natalie Kinstler, Monica L Miller, Sotiris Antoniou, Sadeer Fhadil, Mital Patel, Paul Wright

Open access · goldFull text read
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ellen SchellhasePurdue University College of Pharmacy, West Lafayette, IN 47907, USA.ORCID 0000-0001-9823-593X
Madeline StankoPurdue University College of Pharmacy, West Lafayette, IN 47907, USA.
Natalie KinstlerPurdue University College of Pharmacy, West Lafayette, IN 47907, USA.
Monica L MillerPurdue University College of Pharmacy, West Lafayette, IN 47907, USA.
Sotiris AntoniouSt. Bartholomew's Hospital, London EC1A 7BE, UK.
Sadeer FhadilSt. Bartholomew's Hospital, London EC1A 7BE, UK.
Mital PatelSt. Bartholomew's Hospital, London EC1A 7BE, UK.
Paul WrightSt. Bartholomew's Hospital, London EC1A 7BE, UK.
Purdue University West Lafayette · USSt Bartholomew's Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For patients with cardiac implantable electronic devices (CIEDs), arrythmias such as atrial fibrillation (AF) can be detected and actions taken to rapidly assess and initiate treatment where appropriate. Actions include timely initiation of anticoagulation, review of blood pressure, and optimization of cholesterol/lipids to prevent unfavorable outcomes, such as stroke and other cardiovascular complications. Delays to initiating anticoagulation can have devastating consequences. We sought to implement a virtual clinic, where a pharmacist reviews patient referrals from a CIED clinic after detecting AF from the CIED. Anticoagulation choice is determined by patient-specific factors, and a shared patient-provider decision to start oral anticoagulation is made. In addition, blood pressure readings and medications are assessed with lipid-lowering therapies for optimization. A total of 315 patients have been admitted through this clinic and anticoagulated over a two-year span; in addition, 322 successful interventions were made for optimization of cardiac therapy. Rapid initiation of anticoagulation within five days of referral was likely to have reduced unfavorable outcomes, such as stroke and other cardiovascular optimizations, leading to improved patient outcomes.

Indexed as

anticoagulationatrial fibrillationcardiac implantable electronic devicescardiac pharmacistscardiovascular optimizationdirect oral anticoagulantsmedication optimizationnon-vitamin k oral anticoagulants

Identifiers

PMID36961026
PMCPMC10037589
OpenAlexW4323318656

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read16
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.